AfterQuery | $30,000,000 | (Apr 10, 2026)
Plume (YC S24) | $3,900,000 | (Apr 10, 2026)
Rork | $15,000,000 | (Apr 10, 2026)
Certified by Founder
Lodge
Kincell Bio
start up
United States
- Durham, NC
- 16/05/2025
- Unknown
- $22,000,000
Kincell Bio partners with innovators to advance autologous and allogeneic cell therapies for patients in need of therapeutic solutions. With manufacturing facilities located in Research Triangle Park, NC, and Gainesville, FL, Kincell Bio is a Cell therapy CDMO with the mission to streamline CMC development, apply expertise in analytical and process development, and facilitate quality-first, reliable GMP supply from early clinical to pivotal studies and product launch.
Kincell Bio’s platform offers clients a personalized, responsive, and expert-driven approach to process development and manufacturing from early clinical to pivotal supply and commercial launch, ensuring rapid timelines without compromising on quality.
- Industry Pharmaceutical Manufacturing
- Website https://kincellbio.com/
- LinkedIn https://www.linkedin.com/company/kincellbio/
Haast | $12,000,000 | (Apr 10, 2026)
CareGlance Srl | $4,092,182 | (Apr 10, 2026)
Elorian AI | $55,000,000 | (Apr 10, 2026)
TeiaCare & Ancelia: AI for Care Homes | $8,184,645 | (Apr 10, 2026)
Sigma Automate | $2,750,000 | (Apr 10, 2026)
Felix(1) | $1,700,000 | (Apr 10, 2026)
Aria Networks, Inc. | $125,000,000 | (Apr 9, 2026)
Trent AI | $13,000,000 | (Apr 9, 2026)
Golden Analytics | $7,000,000 | (Apr 9, 2026)